Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T22:13:42.828Z.
Calculation as of: 2026-10-06T22:13:42.828Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0deb7c30adcc78f114172cbc577a9cc7a44fb527f6444d978a27313071d44bdc
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
TScan Therapeutics, Inc.
Market Cap
$16.82M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$16.84M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$16.74M
Free Cash Flow Yield
N/A
TTM Avg
0.19%
3Y Avg
0.17%
5Y Avg
0.17%
Market Cap
$16.64M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$16.52M
Free Cash Flow Yield
N/A
TTM Avg
2.46%
3Y Avg
5.26%
5Y Avg
3.35%
Market Cap
$17.39M
Free Cash Flow Yield
N/A
TTM Avg
7.21%
3Y Avg
5.84%
5Y Avg
5.84%
Market Cap
$15.78M
Free Cash Flow Yield
N/A
TTM Avg
3.99%
3Y Avg
3.12%
5Y Avg
3.97%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| TScan Therapeutics, Inc. (TCRX) | $16.82M | N/A | N/A | N/A | N/A |
| Marker Therapeutics, Inc. (MRKR)vs › | $16.84M | N/A | N/A | N/A | N/A |
| Palatin Technologies, Inc. (PTN)vs › | $16.74M | N/A | 0.19% | 0.17% | 0.17% |
| Bionano Genomics, Inc. (BNGO)vs › | $16.64M | N/A | N/A | N/A | N/A |
| PAVmed Inc. (PAVM)vs › | $17.07M | N/A | N/A | N/A | N/A |
| Dyadic International, Inc. (DYAI)vs › | $16.52M | N/A | 2.46% | 5.26% | 3.35% |
| Lipocine Inc. (LPCN)vs › | $17.31M | N/A | N/A | N/A | N/A |
| Cosmos Health Inc. (COSM)vs › | $17.39M | N/A | 7.21% | 5.84% | 5.84% |
| BioCardia, Inc. (BCDA)vs › | $15.78M | N/A | 3.99% | 3.12% | 3.97% |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.68M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
